Literature DB >> 427518

Treatment failure with penicillin in early syphilis.

A J Giles, A G Lawrence.   

Abstract

A patient with primary syphilis had a recurrence of his penile chancre after generally acceptable penicillin treatment. Retreatment with a similar but extended penicillin regimen was successful. This is the first report of such a treatment failure.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 427518      PMCID： PMC1045584          DOI： 10.1136/sti.55.1.62

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN： 0007-134X


  4 in total

1.  Treatment for early syphilis and reactivity of serologic tests.

Authors:  A L Schroeter; J B Lucas; E V Price; V H Falcone
Journal:  JAMA       Date:  1972-07-31       Impact factor: 56.272

2.  Failure of penicillin in a newborn with congenital syphilis.

Authors:  J B Hardy; P H Hardy; E H Oppenheimer; S J Ryan; R N Sheff
Journal:  JAMA       Date:  1970-05-25       Impact factor: 56.272

3.  Treatment of seropositive primary syphilis: an evaluation of 196 patients.

Authors:  N J Fiumara
Journal:  Sex Transm Dis       Date:  1977 Jul-Sep       Impact factor: 2.830

4.  Treatment of secondary syphilis: an evaluation of 204 patients.

Authors:  N J Fiumara
Journal:  Sex Transm Dis       Date:  1977 Jul-Sep       Impact factor: 2.830
  4 in total
  3 in total

1.  [Syphilis treatment. German and international guidelines--a comparison].

Authors:  H Schöfer
Journal:  Hautarzt       Date:  2005-02       Impact factor: 0.751

2.  In vitro culture system to determine MICs and MBCs of antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain).

Authors:  S J Norris; D G Edmondson
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

3.  Kinetic study of serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people.

Authors:  P Collart; M Poitevin; A Milovanovic; A Herlin; J Durel
Journal:  Br J Vener Dis       Date:  1980-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.